Tg Therapeutics Inc (TGTX)

EBITDA

$134.26M

TTM · Period ending: · USD

TGTX logo

TGTX EBITDA

Latest reported$134.26M
TGTX TTM EBITDA (-$2.80M → $134.26M)
High-resolution chart · PNG

TGTX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-256,713
-1,881,168
-3,086,397
-6,028,149
-5,583,498
-3,202,675
-2,800,000
-3,000,000
-3,700,000
-2,200,000
-2,500,000
-3,300,000
-3,100,000
-5,600,000
-5,100,000
-4,700,000
-4,800,000
-3,700,000
-2,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.